Phibro Animal Health Corporation Reports Second Quarter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Phibro Animal Health Corp. (PAHC) PT Raised to $34 at Piper Jaffray
February 8, 2017 9:17 AM ESTPiper Jaffray raised its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $34.00 (from $32.00) while maintaining a Overweight rating. Phibro reported in-line revenues and upside to earnings for 2Q17, where revenues of $192M were only slightly below the Street's estimates of $193M, while... More
Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
February 6, 2017 4:18 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $191.6 million versus the consensus estimate of $192.92 million.
FINANCIAL GUIDANCE
We have reaffirmed our financial guidance for the fiscal year 2017 as initially... More
